President Obama signed the American Recovery and Reinvestment Act of 2009 (Recovery Act or ARRA) on February 17, 2009. This unprecedented effort aims to stimulate our economy, create or save millions of jobs, and address multiple challenges so our country can thrive.
The NICHD is participating in a number of Funding Opportunities related to the Recovery Act to help fulfill the Act’s goals by stimulating the economy through support of biomedical research. For a listing of those Funding Opportunity Announcements (FOAs), please visit http://www.nichd.nih.gov/recovery/Funding/Pages/index.aspx.
Additional information about the Recovery Act FOAs and related NIH opportunities is available through the Office of Extramural Research at http://grants.nih.gov/recovery.
Areas of Scientific Priority for NICHD
The NICHD places priority on using Recovery Act funds for grants in the following scientific areas:
- Developmental Biology and Perinatal Medicine Complex biological processes, which determine health and well-being, begin even before conception, and fetal and early childhood development set the stage for physical, cognitive, and behavioral outcomes throughout life. A major NICHD priority is to advance fundamental and clinical knowledge about maternal health and problems of child development. This research includes (but is not limited to):
- Basic research on the biochemical, molecular biology, genetic, and cellular mechanisms of early development; contact: Tyl Hewitt, Ph.D., Chief, Developmental Biology, Genetics, and Teratology (DBGT) Branch, (301) 496-5543, firstname.lastname@example.org;
- Biomedical, biobehavioral, clinical, and translational research to prevent or ameliorate intellectual and developmental disabilities, including (but not limited to) such conditions as intellectual disability, Fragile X, autism spectrum disorders (ASDs), and Down syndrome; contact: Melissa Parisi, M.D., Chief, Intellectual & Developmental Disabilities (IDD) Branch, (301) 435-6880, email@example.com; and
- Basic, clinical, and translational research on maternal health, pregnancy, fetal well-being, labor and delivery, newborn screening, and the developing child; contact: Catherine Spong, M.D., Chief, Pregnancy and Perinatology (PP) Branch, (301) 435-6894, firstname.lastname@example.org.
- Maternal and Child Health To improve maternal and child health in the United States and worldwide, a major priority of the NICHD is to conduct research to address major areas. This research includes (but is not limited to):
- Basic, translational, and clinical research on serious threats to health and quality-of-life, including gestational diabetes, obesity and overweight, mechanisms of cognition and learning, growth retardation, HIV/AIDS, and other congenital infections and diseases; contact: Gilman Grave, M.D., Chief, Endocrinology, Nutrition, and Growth (ENG) Branch, (301) 496-5578, email@example.com; contact: Lynne Mofenson, M.D., Chief, Pediatric, Adolescent, and Maternal AIDS (PAMA) Branch, (301) 435-6870, firstname.lastname@example.org;
- Applied research on the psychological, psychobiological, language, behavioral, and educational development of children; contact: Peggy McCardle, Ph.D. M.P.H., Chief, Child Development and Behavior (CDB) Branch, (301) 435-6863, email@example.com; and
- Advanced clinical research to understand the effects and effectiveness of pharmaceuticals on maternal and child health; contact: Anne Zajicek, M.D., Pharm. M.D., Acting Chief, Obstetric and Pediatric Pharmacology (OPP) Branch, (301) 435-6865, firstname.lastname@example.org.
- Contraception, Reproduction, and Population Research Understanding reproductive health and biology for both men and women is crucial to improving health and quality-of-life around the world. Improved knowledge about human population dynamics is also essential to successful and sustainable communities. This research includes (but is not limited to):
- Basic and clinical research in reproductive health to ultimately improve diagnosis and treatment of reproductive health conditions, such as uterine fibroids, endometriosis, infertility, and pelvic floor and pain disorders, among others; contact: Louis DePaolo, Ph.D., Chief, Reproductive Sciences (RS) Branch, (301) 435-6970, email@example.com;
- Efforts to develop safe, effective, inexpensive, reversible, and acceptable contraceptive methods; contact: Trent Mackay, M.D., M.P.H, Chief, Contraception and Reproductive Health (CRH) Branch, (301) 435-6988, firstname.lastname@example.org; and
- Studies to improve understanding of the causes and consequences of population size and distribution changes, including fertility, migration and immigration, population diversity, and family functioning contact: Rebecca Clark, Ph.D., Acting Chief, Demographic and Behavioral Sciences (DBS) Branch, (301) 496-1175, email@example.com
- Medical Rehabilitation Research Medical rehabilitation research is essential to developing scientific and technical knowledge needed to enhance health, productivity, independence, and quality-of-life for people with disabilities. This research includes (but is not limited to):
- Studies to elucidate the scientific underpinnings of clinical rehabilitation and to understand the mechanisms of recovery and adaptation; contact: Ralph Nitkin, Ph.D., Chief, Biological Sciences and Career Development (BSCD) Program, (301) 402-4206, firstname.lastname@example.org;
- Applying technological advances in engineering and bioengineering to improve the human-environment interface and to restore or enhance an individual’s functional capabilities through assistive technologies, such as prosthetics, wheelchairs, and biomechanical devices; contact: Louis Quatrano, Ph.D., Chief, Behavioral Sciences and Rehabilitation Technologies (BSRT) Program, (301) 402-4221, email@example.com; contact: Nancy Shinowara, Ph.D., Chief, Spinal Cord and Musculoskeletal Disorders and Assistive Devices (SMAD) Program, (301) 435-6838, firstname.lastname@example.org;
- Basic and clinical research to understand the underlying mechanisms of Traumatic Brain Injury (TBI) and stroke, and to assess medical rehabilitation therapies and interventions for people with these conditions; contact: Beth Ansel, Ph.D., Chief, Traumatic Brain Injury (TBI) and Stroke Rehabilitation (TSR) Program, (301) 402-2242, email@example.com; and
- Research on pediatric critical care and rehabilitation to ultimately improve outcomes for children who are survivors of trauma, congenital anomalies, neonatal asphyxia, infections, septic shock, and other less common, but still devastating childhood injuries and illnesses; contact: Carol Nicholson, M.D., Chief, Pediatric Critical Care and Rehabilitation (PCCR) Program, (301) 435-6843, firstname.lastname@example.org.
If you are interested in applying for a FOA related to ARRA, please consult with the NICHD Program/Policy contact listed in the specific FOA. See http://www.nichd.nih.gov/recovery/Funding/Pages/index.aspx for relevant FOAs.
For information about scientific review, contact:
Deborah Henken, Ph.D.
Division of Scientific Review, NICHD
National Institutes of Health
Phone: (301) 496-5541
For financial or grants management information, contact:
Bryan S. Clark, M.B.A.
Chief Grant Managements Officer
Grants Management Branch, Office of the Director, NICHD
National Institutes of Health
Phone: (301) 435-6975
For Information from the Office of Extramural Policy, contact:
Dennis A. Twombly, Ph.D.
Acting Deputy Director, Office of Extramural Policy, NICHD
National Institutes of Health
Office: (301) 451-3371